Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma.

@article{Damian2014TopicalIW,
  title={Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma.},
  author={Diona L. Damian and Robyn P. M. Saw and John F Thompson},
  journal={Journal of surgical oncology},
  year={2014},
  volume={109 4},
  pages={308-13}
}
Topical diphencyprone (DPCP) can be used to treat in transit and cutaneously metastastatic melanoma. To date, 50 patients have received DPCP therapy for at least 1 month at our institution, with complete clearance of cutaneous disease in 46% and partial response in a further 38% of patients. Topical immunotherapy with DPCP is inexpensive and well-tolerated and should be considered in patients with skin metastases unsuitable for or refractory to other forms of therapy. 

From This Paper

Topics from this paper.
18 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

Similar Papers

Loading similar papers…